{"filing":{"accession_number":"0001104659-26-071040","cik":"0001070081","ticker":"PTCT","company_name":"PTC THERAPEUTICS, INC.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"tmb-20260602x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1070081/000110465926071040/tmb-20260602x8k.htm"},"events":[{"id":6429,"run_id":5630,"accession_number":"0001104659-26-071040","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the results of PTC Therapeutics' Annual Meeting held June 2, 2026, including election of four Class I directors, ratification of Ernst \u0026 Young LLP as independent auditor, and approval of a non-binding advisory vote on named executive officer compensation. The filing presents vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.","company_name":"PTC THERAPEUTICS, INC.","ticker":"PTCT","filing_date":"2026-06-05","form":"8-K","submitted_at":null,"items":[{"id":4954,"accession_number":"0001104659-26-071040","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of PTC Therapeutics' Annual Meeting held June 2, 2026, including election of four Class I directors, ratification of Ernst \u0026 Young LLP as independent auditor, and approval of a non-binding advisory vote on named executive officer compensation. The filing presents vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T21:16:05.474607+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4954,"accession_number":"0001104659-26-071040","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of PTC Therapeutics' Annual Meeting held June 2, 2026, including election of four Class I directors, ratification of Ernst \u0026 Young LLP as independent auditor, and approval of a non-binding advisory vote on named executive officer compensation. The filing presents vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T21:16:05.474607+00:00","company_name":"PTC THERAPEUTICS, INC.","ticker":"PTCT","filing_date":"2026-06-05"}]}